Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,979 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,377
Recruiting: 744
Ph III recruiting: 79
Growth YoY: +22.4%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.1%
Trials / 1,000 deaths: 40.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 1–50 of 1,013 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06906471	A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS	active not recruiting	Phase 1 / Phase 2	10	Antelope Surgical Solutions, IncINDUSTRY	1	Sep 29, 2026	clinicaltrials
NCT07100847	Periprostatic Neurolysis in Prostate Cancer	active not recruiting	Phase 1	21	University of Texas Southwestern Medical CenterOTHER	1	Sep 29, 2026	clinicaltrials